Jinhui Holdings (09993.HK): The three red lines of revenue and profit growth are all green and steady happiness
Jinhui Holdings (9993.HK): high quality and steady growth further reduces financing costs
Jinhui Holdings (09993.HK): lower financing costs and pay more attention to high-quality growth
Rongchang Biological (09993.HK): Vidixitumab approved for listing ASCO publishes a number of data
Jinhui Holdings (9993.HK): the inflection point of profit margin of both attack and defense has appeared.
Jinhui Holdings (09993.HK): cash and profit-oriented "three red lines" all turn green
Jinhui Holdings (9993.HK): IPO report
Jinhui Holdings (09993.HK): subscription for new shares
No Data
No Data